Rabies virus like particle production in plants
AssigneeMedicago Inc.
InventorsMarc-Andre D'Aoust, Pierre-Olivier Lavoie, Louis-Philippe Vezina, Manon Couture
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedicago Inc.
InventorsMarc-Andre D'Aoust, Pierre-Olivier Lavoie, Louis-Philippe Vezina, Manon Couture
Estimating the term…
A method of producing a virus like particle (VLP) in a plant is provided. The method comprises introducing a first nucleic acid into the plant, or portion of the plant. The first nucleic acid comprising a first regulatory region active in the plant operatively linked to a nucleotide sequence encoding a native rabies virus structural protein. The nucleotide sequence may further comprise one or more than one amplification element. Optionally, a second nucleic acid might be introduced into the plant, or portion of the plant. The second nucleic acid comprising a second regulatory region active in the plant and operatively linked to a nucleotide sequence encoding a matrix protein, for example but not limited to a rabies matrix protein. The plant or portion of the plant is incubated under conditions that permit the expression of the nucleic acids, thereby producing the VLP.
1-36. (canceled)
A method of producing a rabies virus like particle (VLP) in a plant comprising,
A method of producing a rabies virus like particle (VLP) in a plant comprising,
A plant-derived VLP comprising one or more native rabies glycoprotein (G) wherein the VLP comprises a lipid obtained from the plasma membrane of the plant.
The method of 42, wherein the rabies matrix protein (M) has the amino acid sequence shown as in SEQ ID NO:
Dependencies are inferred from the claim text.